Preamble
Recitals 76
Chapter I - SCOPE AND DEFINITIONS (Article 1-3) 3
Chapter II - APPROVAL OF ACTIVE SUBSTANCES (Article 4-11) 8
Chapter III - RENEWAL AND REVIEW OF APPROVAL OF AN ACTIVE SUBSTANCE (Article 12-16) 5
Chapter IV - GENERAL PRINCIPLES CONCERNING THE AUTHORISATION OF BIOCIDAL PRODUCTS (Article 17-24) 8
Chapter V - SIMPLIFIED AUTHORISATION PROCEDURE (Article 25-28) 4
Chapter VI - NATIONAL AUTHORISATIONS OF BIOCIDAL PRODUCTS (Article 29-31) 3
Chapter VII - MUTUAL RECOGNITION PROCEDURES (Article 32-40) 9
Chapter VIII - UNION AUTHORISATIONS OF BIOCIDAL PRODUCTS (Article 41-46) 6
Chapter IX - CANCELLATION, REVIEW AND AMENDMENT OF AUTHORISATIONS (Article 47-52) 6
Chapter X - PARALLEL TRADE (Article 53) 1
Chapter XI - TECHNICAL EQUIVALENCE (Article 54) 1
Chapter XII - DEROGATIONS (Article 55-57) 3
Chapter XIII - TREATED ARTICLES (Article 58) 1
Chapter XIV - DATA PROTECTION AND DATA-SHARING (Article 59-64) 6
Chapter XV - INFORMATION AND COMMUNICATION (Article 65-73) 9
Chapter XVI - THE AGENCY (Article 74-79) 6
Chapter XVII - FINAL PROVISIONS (Article 80-97) 18
Annexes 7

making available on the market

Definitions over time (1)

25/04/2014 – 29/03/2021 Article 3, Regulation (EU) No 528/2012 Scope: Whole act

For the purposes of this Regulation, the following definitions shall apply:

‘making available on the market’ means any supply of a biocidal product or of a treated article for distribution or use in the course of a commercial activity, whether in return for payment or free of charge;

Each has its own scope, dates and uses. Open one to see when it applies.

Open an entry to see its definitions, dates and uses. Separate scopes and histories are kept intact.

No text uses this concept on 12/11/2026.